The MObyDiCK platform offers a target identification service that identifies first-in-class drug targets and elucidates their mechanisms of action for various diseases by analyzing causal gene regulatory networks.
Read MoreFrom Data to Discovery in 90 Days: That's MObyDiCK
Mapping the Future of Therapeutics
Features
Experience Therapeutic Breakthroughs
Innovative Target Discovery Platform
MObyDiCK is a cutting-edge platform that integrates systems biology and network control theory to identify novel therapeutic targets and predictive biomarkers.
Maximized Efficacy, Minimized Side Effects
By applying cellular reprogramming strategies, MObyDiCK enhances therapeutic efficacy while minimizing off-target effects, enabling precision-targeted interventions.
Validated Results in Just 3 Months
The platform delivers experimentally validated therapeutic targets and biomarkers within 3 months, accelerating the drug discovery pipeline with high reliability.
Single-Cell–Driven Mechanistic Modeling
MObyDiCK integrates single-cell omics and other diverse experimental inputs to build context-specific models and simulate disease processes like cancer and aging.
Try
Try MObyDiCK for Free Today
Please review and agree to the Data Usage Agreement to proceed:
MObyDiCK Platform Service - Free Trial Data Usage Agreement
Last Updated: April 14, 2025
This Data Usage Agreement ("Agreement") governs your use of the free trial version of the MObyDiCK platform service ("Service"), provided by BIOREVERT ("Provider," "we," "us," or "our"). By accessing or using the Service and uploading data, you ("User," "you," or "your") agree to be bound by the terms of this Agreement. If you do not agree to these terms, do not use the Service or upload any data.
1. Purpose of the Service
The Service allows Users, during a limited free trial period ("Free Trial Period"), to upload datasets owned by the User or publicly available datasets ("Data") for the purpose of analysis using the MObyDiCK platform. The Service will process the uploaded Data and provide analysis results ("Results") back to the User.
2. User Responsibilities and Representations
a. Data Ownership and Rights: You represent and warrant that you either own the Data you upload or have obtained all necessary rights, licenses, consents, and permissions to upload, process, and use the Data in connection with the Service as contemplated by this Agreement. This includes, but is not limited to, compliance with any applicable data privacy laws (e.g., GDPR, CCPA), intellectual property rights, and terms of service associated with publicly available datasets.
b. Lawful Use: You agree not to upload any Data that is illegal, infringing, defamatory, harmful, or violates the rights of any third party. You are solely responsible for the content and legality of the Data you upload.
c. Accuracy: While the Service aims to provide accurate analysis, you acknowledge that the Results are based on the Data provided by you. You are responsible for ensuring the quality and suitability of the Data uploaded for analysis.
d. Compliance: You agree to use the Service and the Results in compliance with all applicable laws and regulations.
3. Data Usage by Provider
a. Limited License: You grant the Provider a perpetual, irrevocable, worldwide, royalty-free license to use, copy, modify, analyze, aggregate, anonymize, and create derivative works from the Results generated by the Service from your Data for internal purposes only.
b. No Other Use: The Provider will not use your uploaded Data for any purpose other than providing the Service to you under this Agreement. Specifically, unless explicitly agreed otherwise in writing, the Provider will not use your Data for its own internal research, product development, model training (beyond the immediate processing required to generate your Results), marketing, or any other purpose not directly related to delivering the requested analysis during the Free Trial Period.
c. Public Data: If you upload publicly available data, you remain responsible for adhering to any usage restrictions or attribution requirements associated with that data source. The Provider processes such data under the assumption that you have the necessary rights to do so.
4. Ownership
a. User Data: You retain all ownership rights to the original Data you upload.
b. Analysis Results: Subject to your ownership of the underlying Data, you own the specific Results generated by the Service based on your Data.
c. Service IP: The Provider retains all ownership rights to the Service itself, including the platform, algorithms, software, documentation, and any underlying technology or intellectual property. This Agreement does not grant you any rights to the Provider's intellectual property beyond the limited right to use the Service during the Free Trial Period.
5. Confidentiality and Security
a. Confidentiality: The Provider will treat your uploaded Data as confidential information, except for Data explicitly designated by you as public or already in the public domain.
b. Security: The Provider will implement reasonable technical and organizational measures designed to protect the security, confidentiality, and integrity of your Data during the Free Trial Period. However, you acknowledge that no security measures are perfect or impenetrable, and the Provider cannot guarantee absolute security. You upload Data at your own risk.
c. No Sensitive Personal Data: You agree not to upload highly sensitive personal data (such as financial account numbers, social security numbers, health information, etc.) unless the platform is explicitly designed and secured for such data, and even then, only if you have the explicit legal right and consent to do so.
6. Free Trial Limitations
a. "AS IS" Basis: The Service is provided on a free trial basis "AS IS" and "AS AVAILABLE" without any warranties of any kind, express or implied. The Provider does not warrant that the Service will be uninterrupted, error-free, or meet your specific requirements.
b. No Guarantee of Results: The Provider makes no representations or warranties regarding the accuracy, reliability, or completeness of the Results. You use the Results at your own risk.
c. Limited Support: Support for the free trial version may be limited or unavailable.
d. Duration: Access to the Service under this Agreement is limited to the specified Free Trial Period, which may be terminated or modified by the Provider at any time without notice.
7. Data Retention and Deletion
a. During Trial: Data will be retained as necessary to provide the Service during the Free Trial Period.
b. After Trial: Upon expiration or termination of the Free Trial Period, or upon your request, the Provider will use commercially reasonable efforts to delete your uploaded Data and associated Results from its active systems within a reasonable timeframe (e.g., 30 days), unless retention is required by law or for legitimate archival purposes (subject to ongoing confidentiality obligations). Specific retention timelines may be detailed in our Privacy Policy.
8. Disclaimer of Warranties
EXCEPT AS EXPRESSLY STATED HEREIN, THE SERVICE AND RESULTS ARE PROVIDED "AS IS." THE PROVIDER DISCLAIMS ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT.
9. Limitation of Liability
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL THE PROVIDER OR ITS AFFILIATES, OFFICERS, EMPLOYEES, AGENTS, SUPPLIERS, OR LICENSORS BE LIABLE FOR ANY INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATING TO THE USE OF, OR INABILITY TO USE, THE SERVICE OR RESULTS, EVEN IF THE PROVIDER HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
THE PROVIDER'S TOTAL CUMULATIVE LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE FREE TRIAL SERVICE, WHETHER IN CONTRACT, TORT, OR OTHERWISE, SHALL NOT EXCEED TEN US DOLLARS ($10.00 USD).
10. Indemnification
You agree to defend, indemnify, and hold harmless the Provider, its affiliates, officers, directors, employees, and agents from and against any and all claims, damages, obligations, losses, liabilities, costs, or debt, and expenses (including but not limited to attorney's fees) arising from: (i) your use of and access to the Service; (ii) your violation of any term of this Agreement; (iii) your violation of any third-party right, including without limitation any copyright, property, or privacy right; or (iv) any claim that your Data caused damage to a third party.
11. Modification of Agreement
The Provider reserves the right to modify this Agreement at any time. We will notify you of significant changes, potentially via the Service interface or email. Your continued use of the Service after such modifications constitutes your acceptance of the revised Agreement.
12. Governing Law
This Agreement shall be governed by and construed in accordance with the laws of REPUBLIC OF KOREA, without regard to its conflict of law principles.
13. Entire Agreement
This Agreement, together with any Privacy Policy referenced herein, constitutes the entire agreement between you and the Provider regarding the use of the Free Trial Service and supersedes all prior or contemporaneous communications and proposals, whether electronic, oral, or written.
14. Acceptance
By clicking "Agree & Continue," creating an account, uploading Data, or otherwise using the MObyDiCK Free Trial Service, you acknowledge that you have read, understood, and agree to be bound by this Data Usage Agreement.
MObyDiCK Service Guide
File1.gz
- metadata.csv
- barcodes.tsv.gz
- features.tsv.gz
- matrix.mtx.gz
OR
File2.gz
- data.h5ad
OR
File3.gz
- count.csv
- metadata.csv
Upload only one of the following archive files: File1.gz, File2.gz, or File3.gz. All uploaded files must be .gz compressed. Make sure cell IDs are consistent between expression and metadata files. If using .h5ad, pseudotime must be accessible via adata.obs["pseudotime"] or adata.obsm["pseudotime"].
This standardized input structure ensures compatibility with the MObyDiCK beta service. For support, contact mobydick@biorevert.com. Let us know if you require specific adjustments (e.g., for R or Python workflows).
LEVEL 1A Summary of Network Models
Properties of the network models (e.g., number of ensemble models, nodes, and edges), as well as details of Boolean functions per node.
LEVEL 2Target/Biomarker Identification
Lists of target genes for therapeutic intervention or biomarkers for predicting treatment response, depending on the service type.
LEVEL 3In Silico Validation
Detailed analysis of network-level mechanisms.
LEVEL 4In Vitro Validation
In vitro validation results of identified targets via cell-based phenotype assays (e.g., proliferation, marker gene expression ).
• Target Identification Service
The MObyDiCK platform offers a target identification service that identifies first-in-class drug targets and elucidates their mechanisms of action for various diseases by analyzing causal gene regulatory networks.
• Biomarker Identification Service
The MObyDiCK platform offers a biomarker identification service that utilizes systems biology and single-cell omics to construct causal gene regulatory networks, enabling precise predictive biomarker discovery with results guaranteed within 3 months.
Timeline
Explore the 3-Month Innovation Process
1st Month
- Data pre-processing
- Network model construction
- Large-scale computer simulation
2nd Month
- Network model validation
- Target discovery
- In silico target validation
- Design in vitro validation experiments
3rd Month
- In vitro target validation
Explore
Our Unique Services
Target Identification Service
Biomarker Identification Service
The MObyDiCK platform offers a biomarker identification service that utilizes systems biology and single-cell omics to construct causal gene regulatory networks, enabling precise predictive biomarker discovery with results guaranteed within 3 months.
Read MoreContact Us
for Our Enterprise Service
Feel free to send us an inquiry
Ready to discuss our Enterprise Service? Simply complete the form below. Our team will review your details and get back to you within 3 business days!
Some Important FAQ's
Common Frequently Asked Questions
A: The MObyDiCK service constructs network models to represent the mechanistic and causal relationships underlying cellular processes, extending beyond simple correlations. In these models, nodes typically correspond to genes, but may also represent proteins or other regulatory factors within the biological system. Edges denote the regulatory interactions between the nodes; an edge directed from node A to node B indicates that A influences the state or activity of B. Edges are typically characterized by the type of regulation, such as activation (positive influence, e.g., transcription factor activating a gene) or inhibition (negative influence, e.g., a repressor blocking gene expression). The overall network structure is defined by the collection of nodes and edges. By specifying the regulatory logic that governs the state of each node within the structure, a dynamical network model is constructed.
A: While the Free Trial allows users to explore the potential of platform, the Enterprise Service ensures robust and reproducible results through optimized data handling and expert-guided parameter tuning. The MObyDiCK service offers tiered access to accommodate diverse user needs:
Free Trial
- Provides limited analysis results without rigorous evaluation in parameter settings;
- Does not guarantee user-requested analytic results (level 1-4), as feasibility depends on input data quality (e.g., scRNA-seq dataset size), problem complexity, feature availability, and parameter settings.
Enterprise Service
- Grants full, unrestricted access to all service capabilities, including advanced systems biology and AI tools and priority support;
- Supports large-scale datasets, custom analytic workflows, and tailored biomarker/target identification services.
- Include dedicated technical assistance, enhanced security protocols, and organization.
A: The key differentiator emphasized for MObyDiCK is its focus on constructing causal gene regulatory networks to understand the underlying biological mechanisms. Unlike AI algorithms that prioritize pattern recognition predictions (e.g., disease state classification), MObyDiCK explicitly analyzes causal relationships between genes, providing interpretable models of system behavior. This mechanistic approach enables precise identification of a small set of feasible drug targets or biomarkers, avoiding the broad gene screening typical of many AI algorithms.